Fink Eric Insider Trades

Insider Trading History

Track insider trading activity for Fink Eric. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $353k 5,161 shares
Last Trade
May 10, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19k 500 shares
$37.96
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $319k 4,661 shares
Last Trade
Mar 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$38.2k 859 shares
$44.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $2.65M 38,739 shares
Last Trade
Mar 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.71M 60,841 shares
$44.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $1.07M 15,625 shares
Last Trade
Mar 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$139k 3,125 shares
$44.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $378k 5,520 shares
Last Trade
Mar 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$139k 3,125 shares
$44.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $164k 2,395 shares
Last Trade
Feb 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$46.9k 947 shares
$49.49
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $1.24M 18,120 shares
Last Trade
Feb 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 3,020 shares
$49.49
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $229k 3,342 shares
Last Trade
Feb 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 3,020 shares
$49.49
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $22.1k 322 shares
Last Trade
Feb 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.9k 322 shares
$49.49
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $0 0 shares
Last Trade
Oct 05, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$272k 4,532 shares
$60.00
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $1.28M 18,750 shares
Last Trade
Sep 01, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 6,250 shares
$60.45
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $428k 6,250 shares
Last Trade
Sep 01, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$378k 6,250 shares
$60.45
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $310k 4,532 shares
Last Trade
Sep 01, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$104k 1,718 shares
$60.45
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $65.1k 950 shares
Last Trade
Aug 05, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$171k 2,454 shares
$69.62
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $1.45M 21,140 shares
Last Trade
Aug 01, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$204k 3,020 shares
$67.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $225k 3,283 shares
Last Trade
Aug 01, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$204k 3,020 shares
$67.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $168k 2,454 shares
Last Trade
Aug 01, 2020 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$55.9k 829 shares
$67.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $18k 263 shares
Last Trade
Jul 31, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.7k 263 shares
$67.48
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $2.9M 42,400 shares
Last Trade
Jun 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.91M 42,400 shares
$68.67
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Human Resources Officer
Holding Value $2.64M 38,500 shares
Last Trade
Feb 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.12M 62,660 shares
$65.82
$68.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up